New findings at a dose methotrexate in treating rheumatoid arthritis

Result code in IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00023728%3A_____%2F16%3AN0000058" target="_blank" >RIV/00023728:_____/16:N0000058 - isvavai.cz</a>

Result on the web

—

DOI - Digital Object Identifier

—

Result language

čeština

Original language name

Nové poznatky při dávkování metotrexátu v léčbě revmatoidní artritidy

Original language description

Methotrexate administered alone or in combination with other conventional disease modifying or biologic drugs is still recommended as first choice in the treatment of rheumatoid arthritis. Until now there has been no study that examined the relationship above doses of MTX, which will be safe, but there are also sufficiently effective in combination with anti-TNF-alpha. The first such work is CONCERTO study, which evaluates various doses of MTX in combination with adalimumab. This paper deals with a new look at dose methotrexate as monotherapy and in combination with biological agents and gives an overview of the general principles of treatment in rheumatoid arthritis with methotrexate monotherapy and in combination with other drugs.

Czech name

Nové poznatky při dávkování metotrexátu v léčbě revmatoidní artritidy

Czech description

Methotrexate administered alone or in combination with other conventional disease modifying or biologic drugs is still recommended as first choice in the treatment of rheumatoid arthritis. Until now there has been no study that examined the relationship above doses of MTX, which will be safe, but there are also sufficiently effective in combination with anti-TNF-alpha. The first such work is CONCERTO study, which evaluates various doses of MTX in combination with adalimumab. This paper deals with a new look at dose methotrexate as monotherapy and in combination with biological agents and gives an overview of the general principles of treatment in rheumatoid arthritis with methotrexate monotherapy and in combination with other drugs.

Type

J_x - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)

CEP classification

FE - Other fields of internal medicine

OECD FORD branch

—

Project

—

Continuities

V - Vyzkumna aktivita podporovana z jinych verejnych zdroju

Publication year

2016

Confidentiality

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Name of the periodical

Acta medicinae

ISSN

1805-398X

e-ISSN

—

Volume of the periodical

5

Issue of the periodical within the volume

7

Country of publishing house

CZ - CZECH REPUBLIC

Number of pages

3

Pages from-to

34,36,39,

UT code for WoS article

—

EID of the result in the Scopus database

—